Delayed screenings as a result of the COVID-19 pandemic have led to later-stage cancer diagnoses, a small study published Feb. 15 in JAMA Network Open suggests.
Oncology
Yale Cancer Center recently made several leadership changes.
The use of genomic sequencing to predict the likelihood that gastric cancer patients will benefit from chemotherapy or from immunotherapy has been validated by findings in a study published Feb. 9 in Nature Communications.
While the White House's revival of the Cancer Moonshot — a program to cut cancer deaths by 50 percent over the next 25 years — is an ambitious and important goal, more can be done today to benefit cancer patients,…
Recent cancer research has findings on cancer trends among African Americans and the impact of COVID-19 on cancer research.
Advertisement
Yale Cancer Center appointed Roy Herbst, MD, its inaugural deputy director of clinical affairs at the center and New Haven, Conn.-based Smilow Cancer Hospital, the center said last week.
Breast cancer has replaced lung cancer as the leading cause of cancer death among African American women, according to a report published Feb. 10 in CA: A Cancer Journal for Clinicians.
Yale Cancer Center named three new leaders Feb. 10.
Gilbert, Ariz.-based Banner MD Anderson Cancer Center launched a cancer therapeutics research institute, AZBigMedia reported Feb. 10.
These four oncologists joined new practices or received new appointments over the last few weeks.